Hotline: 1800 102 2007
Hotline: 1800 102 2007
Mar, 22 2019

J&J enters into agreement with Monash University to advance novel technology

The agreement has been signed between both of them to advance the development of an inhaled version of oxytocin in order to help prevent and manage Post-Partum Hemorrhage (PPH).

J&J enters into agreement with Monash University to advance novel technology

Janssen Pharmaceutica N.V, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, has signed a sponsored research agreement with the Monash Institute of Pharmaceutical Sciences (MIPS) at Monash University.

The agreement has been signed between both of them to advance the development of an inhaled version of oxytocin in order to help prevent and manage Post-Partum Hemorrhage (PPH).

Jaak Peeters, Global Head, Johnson & Johnson Global Public Health, Janssen-Cilag GmBH, said, “When you consider the lifetime risk of dying for a woman in childbirth is 23 times higher in resource-limited settings than anywhere else you must act if you have the scientific capabilities to potentially help overcome that inequity. We hope to address this significant unmet need by helping accelerate the development of what would be a truly life-saving innovation and give women and their families everywhere the same chance at life.”

Michelle McIntosh, Monash Institute of Pharmaceutical Sciences, Monash University, added, “This is an exciting opportunity to expand this collaboration between industry and academia to develop an important healthcare innovation that aims to address a critical unmet medical need. There is a massive ripple effect when a mother dies – it's a very significant burden for these families and communities, and we are committed to bringing the gold-standard care to all mothers.”

Kathy Connell, Senior Director, New Ventures, Australia & New Zealand, Johnson & Johnson Innovation, further stated, “This latest agreement between Johnson & Johnson and Monash University, an internationally renowned leader in pharmacy and pharmacology, builds on our legacy of innovative academic-industry collaborations in Australia focused on developing life-saving treatments for the highest unmet needs.”

sharebtn
Comment
user
email
mobile
address
star
Related opportunities
  • Tea And Coffee Chain
    About Us: We serve our tea the way Indians like best!! Freshly..
    Locations looking for expansion DELHI
    Establishment year 2008
    Franchising Launch Date 2009
    Investment size Rs. 10lac - 20lac
    Space required 50
    Franchise Outlets -NA-
    Franchise Type Unit, Multiunit
    Headquater DELHI DELHI
  • Three Wheeler (Auto) Showroom
    About Us: Here comes the opportunity to become your own boss..
    Locations looking for expansion Uttar pradesh
    Establishment year 2013
    Franchising Launch Date 2013
    Investment size
    Space required 1200
    Franchise Outlets -NA-
    Franchise Type -NA-
    Headquater Meerut Uttar pradesh
  • Men's Footwear
    Established in 2003, Mr. Pronto is a Chennai-based brand engaged..
    Locations looking for expansion Tamil nadu
    Establishment year 2003
    Franchising Launch Date 2020
    Investment size Rs. 20lac - 30lac
    Space required 150
    Franchise Outlets -NA-
    Franchise Type Unit
    Headquater Chennai Tamil nadu
  • Pharmacies
    A leading Retail Medical Shop with all kinds of Allopathic..
    Locations looking for expansion Chhattisgarh
    Establishment year 1970
    Franchising Launch Date 2021
    Investment size Rs. 5lac - 10lac
    Space required 400
    Franchise Outlets -NA-
    Franchise Type Unit
    Headquater Raipur Chhattisgarh
Daily Updates
Submit your email address to receive the latest updates on news & host of opportunities